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ABSTRACT
Phosphorylation and O-GlcNAc modification often
induce conformational changes and allow the protein
to specifically interact with other proteins. Interplay
of phosphorylation and O-GlcNAc modification at the
same conserved site may result in the protein under-
going functional switches. We describe that at con-
served Ser/Thr residues of human Oct-2, alternative
phosphorylation and O-GlcNAc modification (Yin
Yang sites) can be predicted by the YinOYang1.2
method. We propose here that alternative phospho-
rylation and O-GlcNAc modification at Ser191 in the
N-terminal region, Ser271 and 274 in the linker region
of two POU sub-domains and Thr301 and Ser323 in
the POUh subdomain are involved in the differential
binding behavior of Oct-2 to the octamer DNA motif.
This implies that phosphorylation or O-GlcNAc modi-
fication of the same amino acid may result in a dif-
ferent binding capacity of the modified protein. In
the C-terminal domain, Ser371, 389 and 394 are addi-
tional Yin Yang sites that could be involved in the
modulation of Oct-2 binding properties.
INTRODUCTION
Sequence-specific protein–DNA recognition is mediated by
families of related structural motifs including the helix–
turn–helix (1), helix–loop–helix (2), Zn finger (3), leucine
zipper/bZIP (4) and POU (Pit, Oct, Unc) motifs (5). The
octamer-binding proteins represent an extended subfamily
of POU-motif-containing proteins with related protein
sequences and similar DNA-binding specificities. The
members of this subfamily (designated Oct-l, Oct-2, Oct-3,
etc.) recognize an evolutionarily conserved octanucleotide
sequence in the vertebrate promoter and enhancer elements
(50-ATGCAAAT-30). It has been shown that the Oct-2 gene is
expressed as multiple mRNAs that vary in splicing patterns
(6), thus generating multiple Oct-2 isoforms.
Oct-2 is a transcription factor expressed in the B lympho-
cyte lineage and in the developing central nervous system that
functions through a number of discrete protein domains. These
include a DNA-binding POU homeodomain flanked by two
transcriptional activation domains (7). Oct-2 also contains a
potential ‘leucine zipper’ domain consisting of four leucines
separated each by exactly seven residues. The role of the
leucine zipper domain in Oct-2 has not been demonstrated
in DNA binding. H1-NMR spectral studies (8) revealed the
existence of a bipartite POU domain consisting of two isolated
sub-domains, the N-terminal POU-specific (POUs) and the
C-terminal variant POU homeodomain (POUh), with a flexible
linker portion (8,9). The POU-specific sub-domain is critical
for high-affinity, sequence-specific DNA binding, but requires
the POU homeodomain for fully efficient DNA binding. On
the other hand, the isolated homeodomain is capable of low-
affinity DNA binding and specific protein–protein interactions
(7,10). In vitro studies have shown that the C-terminal activa-
tion domain (a serine-, threonine- and proline-rich sequence)
is capable of activating transcription from a distance in a B-
cell-specific manner.
Induction of post-translational modifications (PTMs) in
transcription factors constitutes a common mechanism to regu-
late gene expression. One of the most common PTMs in tran-
scription factors is phosphorylation that regulates their activity
in response to different extra- and intracellular signals, enab-
ling convergence of different signaling pathways at the same
factor. There is sufficient evidence to suggest that phospho-
rylation changes in the POU-domain modulate the ability of
the protein to activate transcription (11). Phosphorylated Oct-2
is indeed more competent to activate transcription than the
non-phosphorylated molecule (12).
Linkages in which the sugar is covalently attached to an
amino acid containing a hydroxyl group occur in great variety
of proteins, not only in regard to the partners in this linkage but
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also in different anomeric configurations. Every amino acid
with a hydroxyl functional group (i.e. Ser, Thr, Tyr, Hyp
[hydroxyproline] and Hyl [hydroxylysine]) has been impli-
cated. The common O-glycosidic linkages occurring in gly-
coproteins are GalNAc-a-Ser/Thr and GlcNAc-b-Ser/Thr.
The O-GlcNAc modification has been found to be as dynamic
and regulatory as phosphorylation (13–15). Interplay between
GlcNAc modification and phosphorylation has been observed
in many nuclear and cytoplasmic proteins (13–15). O-GlcNAc
modification in transcription factors has been shown to be
involved in modulating the function of these proteins (16).
Protein functions are determined by their 3D structures and
the folded 3D structure is in turn governed by the primary
structure, and the PTMs the protein undergoes during synthe-
sis and transport. Defining protein functions in vivo in the
cellular and extra cellular environments remains a daunting
task due to the presence of innumerable other molecules.
However, the phosphorylations and O-GlcNAc modifications
taking place during and after protein folding are directly
related to the modification potential and not only determined
by the primary structure or sequence. These PTMs are
dynamic and result in temporary conformational changes
that regulate many functions of the protein.
Computer-assisted studies therefore could help in determin-
ing protein functions by assessing the modification potentials
of a given protein. Computational methods in biological sci-
ences have played a crucial role in understanding genomics,
proteomics and defining the contribution of phosphorylation,
sulfation and glycosylation in various contexts of functional
protein regulation. Several programs based on artificial neural
networks have been developed to predict glycosylation and
phosphorylation sites in proteins with reliable accuracy
(Table 1). In most cases, the prediction accuracy is very
high except when the modification potential of a protein
could be wrongly assessed because a false negative site had
been predicted. For example, a Ser residue may have a very
high predicted potential for phosphorylation and a potential
for O-GlcNAc slightly lower than the threshold. This may
result in a false negative Yin Yang site. In fact, both kinase
and OGT may have as good an access to a Ser to phosphorylate
it or add a O-GlcNAc moiety so that the Ser in question can
be considered a bona fide Yin Yang site. Moreover the pres-
ence of certain amino acids around a Ser/Thr affects its glyco-
sylation and phosphorylation and has been shown important
for modification.
In this paper, we describe potential glycosylation, phospho-
rylation and their possible interplay sites in various domains of
Oct-2 that have been predicted and analyzed, using the dif-
ferent prediction methods available. The possible roles played
by these PTMs in proper functioning of the multifunctional
Oct-2 protein are analyzed on the basis of potential glycosy-
lation and phosphorylation interplay sites in evolutionarily
conserved residues of Oct-2. The conserved phylogenetic
motifs and/or residues are known to act as key functional
sites (17,18) and the PTMs at conserved residues may act
as regulatory sites for certain protein functions.
MATERIALS AND METHODS
Sequence data
The sequence of human Oct-2 has been described by many
workers (19,20). The sequence data used for predicting phos-
phorylation and glycosylation sites for Oct-2 of Homo sapiens
were retrieved from the SWISS-PROT (21) sequence database
with entry name PO2F2_HUMAN and primary accession
number P09086. BLAST search was made using the NCBI
database of non-redundant sequences (22). The search was
made for all organisms’ sequences with expect value set to
10 using blosum62 matrix and low complexity filter selecting
nr database. A total of 506 hits were obtained. Of these 506
blast hits the first 13 with highest bits score and zero expect
value were all from mammals including that of human, mouse,
rat and pig, and all these sequences showed at least 70%
identity. These 13 mammalian sequences were multiply
aligned using CLUSTALW (23) and from these 13, a total
of 5 corresponding to human, mouse, rat, dog and pig
sequences were selected. Isoforms of the selected sequences
were neglected. Another mammalian sequence from Canis
familiaris with a higher bits score was also selected. No
Oct-2 hit was found in amphibians. One fragment sequence
found in these blast hits from Gallus gallus, named Oct-2, was
also selected. Two homologous sequences from catfish named
Oct-2a and b with the same expect value and almost same bits
score were found. Oct-2a with slightly lower bits score was
ignored, whereas Oct-2b was selected for final multiple align-
ment. A sequence from Drosophila named dOct-2 was also
selected as an invertebrate representative to find out its degree
of divergence of dOct-2 with human Oct-2. Many homologous
sequences to the POU domain family were also ignored from
various organisms, so as to minimize the number of sequences
to be aligned.
To find out conserved residues in human Oct-2, six
sequences from the Blast search were finally selected. Of
the six, four from mammals (dog, mouse, rat and pig Oct-2),
one from fish (catfish Oct-2b) and one from Drosophila
(dOct-2) were selected. The sequence data from dog (Canis
familaris) was shortened by removing 630 N-terminal amino
acids from a total of 1242. The sequence fragment of Gallus
(chicken Oct-2) was not included in the final list of multiple
alignments, as it was actually a homeobox region with POU
domain-like fragment. All seven sequences (Table 2) were
aligned using CLUSTALW (23). First alignment was made
only for sequences from mammals and these mammalian
sequences were multiply aligned with catfish Oct-2, and
then with Drosophila dOct-2, one by one and then for all,
to find out the degree of divergence of the different sequences.
Phylogenetic trees were calculated using CLUSTALW that
uses a distance-based algorithm for calculating phylogenetic
divergence.
Table 1. Percentage accuracy of prediction methods
S. no. Prediction
methods
Percentage accuracy
Glycosylated/
phosphorylated
(%)
Non-glycosylated/
non-phosphorylated
(%)
Overall
(%)
01 NetNGlyc1.0 86 61 76.50
02 NetOGlyc 2.0 83 90 86.50
03 DictyoGlyc1.1 97 97 97
04 YinOYang1.2 72.50 79.50 76
05 NetPhos2.0 69 96 82.50
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Sequence logos
Sequence logos represent the patterns in aligned sequences.
They also describe the consensus sequence and depict the
relative frequency of residues and the information content
(measured in bits) at every position in a site or sequence.
The logo displays both significant residues and subtle
sequence patterns (24,25). The Web Logo server at the
University of California, Berkeley, (CA) was used to generate
sequence logos of different regions of Oct-2.
PTMs prediction methods
Methods used for predicting potential O-linked glycosylation
sites include NetOGlyc 2.0, 3.0 (26,27) (http://www.cbs.dtu.
dk/services/NetOGlyc/), that predicts O-glycosylation sites in
mucin-type proteins (i.e. for O-GalNAc sites), DictyOGlyc 1.1
(28) (http://www.cbs.dtu.dk/services/DictyOGlyc/) and
YinOYang 1.2 (http://www.cbs.dtu.dk/services/YinOYang/),
that both predict O-GlcNAc sites in eukaryotic proteins. The
NetNGlyc 1.0 (http://www.cbs.dtu.dk/services/NetNGlyc/)
was used for predicting N-glycosylation sites. The above-
mentioned methods for predicting the glycosylation sites
are neural network-based. To predict phosphorylation sites
in Oct-2, NetPhos 2.0 (29) (http://www.cbs.dtu.dk/services/
NetPhos/) was used. The latter is also a neural network-
based program designed by training the networks with protein
phosphorylation data from Phosphobase 2.0.
Neural networks-based prediction methods
Artificial neural networks are based on the concept that a
neuron receives multiple inputs and gives a single output
based on weights associated with the various outputs
(30,31). The networks are trained with information contained
in the known protein sequences. The O-glycosylation methods
of predictions use back propagation for adjusting the weights
to a set threshold value based on surface accessibility of amino
acid residues (30). The amino acids are represented in the
network by sparse encoding (31). It is an encoding method
in which each amino acid is represented as a series of 21 binary
digits. This encoding is useful as it ensures that each amino
acid is equidistant from any other, so that there is no
pre-correlation between amino acids. The evaluation of the
performance of the neural networks is an important step in
developing the prediction methods and different parameters
are used to reach this goal. Parameters used by different O-
glycosylation prediction methods have almost the same
pattern, with slight differences, as in the case of window
size (in terms of number of amino acids) used to train the
network, to test their performance and number of hidden layers
of neurons. Glycosylation prediction methods evaluate the
performance through cross validation using Matthews’ cor-
relation coefficient (32).
The evaluation of the network performance is obtained by
setting a jury of networks. The number of networks for a
jury and sequence window is different in the various O-
glycosylation prediction methods. The results obtained from
all the networks are sigmoidally arranged and averaged to
obtain a value between zero and one. Usually a threshold
of 0.5 is used for prediction, which means that a site with
an output of more than 0.5 is recognized as having a potential
to be glycosylated. Similarly, Netphos 2.0 is also a neural
network-based prediction method for assessing the possibility
of phosphorylation at serine, threonine and tyrosine. This
method was developed by training the neural networks
with phosphorylation data from the phosphobase similarly
to the method used for training networks for glycosylation
prediction.
The sequence context of glycosylated threonines is found to
be different from that of serines and the charged residues are
disfavored at positions 1 and +3. The method NetOGlyc 2.0
correctly predicts 83% of the glycosylated and 90% of the
non-glycosylated serine and threonine residues in indepen-
dent test sets when the network system is cross validated.
YinOYang 1.2 employed the sequence data to train a jury
of neural networks on 40 experimentally determined O-
GlcNAc acceptor sites for recognizing the sequence context
and surface accessibility. The number of non-acceptor serine/
threonines was reduced from 1251 to 626. The YinOYang
1.2 method (http://www.cbs.dtu.dk/services/YinOYang/) is
efficient in a cross validation test as it correctly identifies
72.5% of the glycosylated sites and 79.5% of the non-
glycosylated sites in the test set, verifying the Matthews’
correlation coefficient of 0.22 on the original data and
0.84 on the augmented data set. The method has the capability
to predict the sites known as Yin Yang sites that can be
glycosylated and alternatively phosphorylated. NetPhos 2.0
predicts phosphorylation on the OH- function of serine,
threonine or tyrosine residues with a sensitivity range from
69 to 96% (29). The present study concentrates on O-
glycosylation of the b-GlcNAc modification, phosphorylation
and their interplay.
RESULTS
Prediction results of Oct-2 for different O-linked and N-linked
glycosylation sites showed that the protein had the potential
for both N-linked and O-linked glycosylation. Among O-
linked glycosylation sites, O-GalNAc and O-GlcNAc were
Table 2. Different Oct-2 proteins used for multiple alignment
S. no. Species Database Sequence ID/accession no. Blast results
E-value Bits score
01 Homo sapiens SWISSPROT PO2F2_HUMAN, P09086 0.00 695
02 Sus scrofa SWISSPROT PO2F2_PIG, Q29013 0.00 678
03 Ratus sp. GenBank AAA40767.1 0.00 678
04 Mus musculus SWISSPROT PO2F2_MOUSE, Q00196 0.00 639
05 Canis familaris RefSeq XP_541592 1 · 10143 510
06 Ictalurus punctatus EMBL CAA73199.1 1 · 10111 405
07 Drosophila melanogaster SWISSPROT PDM2_DROM, P31369 1 · 1061 237
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the most frequent ones. The prediction results for O-GlcNAc
modification showed that there were 26 potential sites highly
predicted to be modified by O-GlcNAc, 18 on Ser residues,
at positions 49, 52, 68, 133, 150, 157, 165, 271, 283, 358,
371, 389, 392, 403, 430, 444, 448 and 452 and 8 on Thr
residues at positions 48, 165, 169, 400, 435, 441, 442 and
445 (Figure 1).
Similarly, the prediction results by Netphos 2.0 for possible
phosphorylation sites showed that Oct-2 possesses a high
potential for phosphate modification. A total of 31 residues
were predicted to be phosphorylated (Figure 2a). These
include 24 Ser (at 13, 25, 49, 52, 54, 59, 68, 71, 191, 241,
249, 271, 274, 278, 284, 302, 323, 371, 389, 394, 396, 448, 452
and 454), 7 Thr (at 32, 172, 239, 301, 408, 435 and 441) and
0 Tyr. The elevated number of potential Ser and the very
low number of Thr, and no predicted potential Tyr for
phosphate modification suggested the possibility that O-
GlcNAc modifications in Oct-2 may selectively affect
phosphorylation at Ser residues. There were 10 Yin Yang
sites according to the prediction results (Ser: 49, 52, 68,
271, 371, 389, 448 and 452; and Thr: 435 and 441), out of
which 6 were in the C-terminal region (Figure 2b).
Besides these, there were many other Ser and Thr residues
that were predicted to be non-glycosylated, but the phospho-
rylation potential predicted was either much higher than the
threshold or very close to it. Interestingly, such residues were
also conserved in all known mammalian Oct-2 and other ani-
mal Oct proteins, such as catfish Oct-2 and Drosophila Oct-2
(Figure 3 and Table 3). Thus, such residues which could be
considered false negatives may nonetheless act as possible
Yin Yang sites other than those predicted by the YinOYang1.2
method (Tables 3 and 4). Table 4 shows all the possible
Figure 1. Graphical representation of potential for O-GlcNAc modification in serine and threonine residues in the human Oct-2 sequence. Green vertical lines show
the potential of S/T residues for O-GlcNAc modification and light blue horizontal wavy line shows threshold for modification potential.
Figure 2. (a) Potential for phosphate modification at serine and threonine residues in the human Oct-2 sequence and (b) sites with potential for both O-GlcNAc and
phosphate, the Yin Yang sites with red asterisk at top.
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potential Yin Yang sites but among these only eight are most
likely to be Yin Yang sites (Table 3). A phylogenetic tree was
generated using CLUSTALW (Figure 4). It is a rootless phy-
logenetic tree showing Drosophila and catfish as an out group.
The sequence of dog Oct-2 also became a member of a larger
clade with catfish and Drosophila but it possesses more
sequence similarity to other mammalian sequences. Poly-
phyletic mammalian sequences were very similar and mono-
phyletic mouse and rat Oct-2 showed even higher sequence
similarity with that of human (Figure 4), suggesting that mam-
malian and other vertebrate Oct-2 sequences form three dis-
tinct diverging phylogenetic categories though their ancestor
may be same. Results shown for multiple alignments include
catfish and Drosophila to compare the conserved residues of
human and mammalian Oct-2 with the more diverging
sequences of Drosophila melanogaster dOct-2 (Figures 3
and 4).
The Web logos of different regions of aligned sequences
show that there are many conserved Ser and Thr residues and
those with modification potential are marked by blue and red
asterisks (Figure 5). Ser/Thr residues with blue asterisk are
those with high potential and for which experimental evidence
is available, will be considered in detail in the Discussion
(Figure 5). Those sites with low modification potential or
with no experimental evidence are marked by a red asterisk
(Figure 5).
Figure 3. Multiple alignments of five mammalian sequences (human, pig, dog, rat and mouse), one from fish (catfish) and one from Drosophila. The consensus
sequence is highlighted by asterisk, conserved substitution by double dot and semiconserved substitution by single dot. Different sequences are ordered as in aligned
results from CLUSTALW and the numbers in parenthesis show position of human Oct-2 sequence aligned with the others.
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DISCUSSION
Knowledge of the 3D structure is a prerequisite for the full
understanding of protein biological functions, as protein–
protein recognition events depend on the precise 3D shape
of modified and non-modified proteins (33,34). However, a
determination of the 3D structure in vivo is extremely difficult,
as a given configuration is constantly being modified by intra-
and intermolecular interactions occurring between proteins
present in body fluids or in the cell.
Most of the structural data available in protein databases
have been determined in vitro by X-ray crystallography and/or
NMR, but this information is only partially relevant to the
dynamic behavior of proteins in vivo. The study of the molecu-
lar interactions between multifunctional proteins in vivo is
likely to be facilitated by computer-assisted techniques that
assess the modification potential of the proteins involved.
The functional classes of transcription activation
domains have been described, either acting only when present
proximally (glutamine rich domains), or when present at both
proximal and distal binding enhancer sites, such as the serine-,
threonine- or proline-rich domains (35). Oct-2 possesses two
activation domains, one of each functional category, and may
influence the expression of targets through different mecha-
nisms, thus acting as multifunctional protein. Mutagenesis
studies have shown that both POU sub-domains of Oct-2
are necessary for binding to a DNA site and that the Oct-2
C-terminal domain is involved in its activation (7). Moreover,
Oct-2 remains non-functional in the absence of the C-terminal
region even if both the POUs and POUh sub-domains are
intact (7). Differential activation by Oct-1 and Oct-2 was
determined to occur by the combination of multiple activation
domains (12) and differential phosphorylation in those activa-
tion domains was put forward as a mechanism for Oct-2
activation (12). The members of Oct-2 family are promoter
and enhancer recognizing transcription factors. Most tran-
scription factors such as promoter-specific (Sp) transcription
factor Sp1 (36) appear to be modified by O-GlcNAc in
their transcriptional activation domains (13), suggesting that
OGT plays a critical role in the control of protein–protein
interactions involved in transcriptional activation.
Direct evidence was provided that O-GlcNAc modification
of transcription factors is involved in transcriptional regula-
tion. For instance, O-GlcNAc modification of the glutamine
rich Sp1 (SpE) peptide was shown to inhibit its ability to
activate transcription (37). The first transcription factor
shown to bear the O-GlcNAc modification was Sp1 (36), a
ubiquitous transcription factor involved in the control of
TATA-less housekeeping gene transcription (38). Homo-
multimerization is necessary for the synergistic activation
of transcription by Sp1 (37), but O-GlcNAc modification of
Sp1 in its C-terminal activation domain dramatically decreases
its binding to the SpE peptide. This has been proposed to
interrupt the hydrophobic interaction of glutamine-rich
regions with their partners and abolish homopolymerization
(37). Similarly, many transcription factors have been
described that are modified by alternative glycosylation and
phosphorylation and this interplay was found to regulate key
functions of these proteins (13,15,36,37). Flexibility of OGT
in recognition of its substrate was described earlier (37). This
flexibility in substrate recognition suggested that OGT recog-
nizes conformational features of numerous transcription fac-
tors rather than a specific sequence motif, suggesting a rather
ubiquitous role of OGT in regulating transcription (37).
During B-lymphocyte maturation, expression of rearranged
IgH and IgL genes is critical and is controlled by a complex
interaction between regulatory DNA elements and transcrip-
tion factors (39). Among the regulatory DNA elements nec-
essary for B-cell-specific transcription, the octamer motif is an
important transcriptional site that is part of promoters and
enhancers of ubiquitously expressed genes.
Table 3. Conserved S/T residues with PTMs potential of human Oct-2 aligned
with that of other animals
S. no. Residue Conservation status Modification potential
Mam Vert Dros Phosphate O-GlcNAc Yin Yang
sites
01 Ser49 * * N HP HP Pr
02 Ser52 * * . VHP HP Pr
03 Ser54 * * * VHP VCT FN
04 Ser59 * * : HP VCT FN
05 Ser68 * N N VHP HP Pr
06 Thr150 * . * VCT HP FN
07 Thr172 * DG . VHP VCT FN
08 Ser191 * * . VHP VCT FN
09 Ser271 * * . HP HP Pr
10 Ser274 * * * VHP VCT FN
11 Ser284 * * . VHP VCT FN
12 Thr301 * * * VHP VCT FN
13 Ser323 * * * VHP VCT FN
14 Ser371 * * * VHP HP Pr
15 Ser389 * * DG HP VHP Pr
16 Ser394 * * : VHP VCT FN
17 Thr435 * . DG HP HP Pr
18 Thr441 * N DG HP HP Pr
19 Ser448 * N DG HP HP Pr
20 Ser452 * N DG HP HP Pr
*, Conserved residue; :, conserved substitution; ., semi-conserved substitution;
N, non conserved substitution; DG, deletion gap; VHP, very high potential;
HP, high potential; VCT, very close to threshold; Pr, predicted by YinOYang
1.1; F.N, false negative; Mam, mammals; Vert, vertebrates; Dros, drosophila.
Note: only those S/T residues are listed in the table which are potential Yin Yang
sites and conserved as well. The proposed Yin Yang sites are highlighted by
bold face.
Table 4. Possible Yin Yang sites in different domains of human Oct-2
S. no. Domain/region Yin Yang sites predicted by YinOYang1.2 Yin Yang sites proposed on the basis of false negative
01 N-terminal region 5 Residues: Ser49, 52, 68 and Thr150, 172) 3 Residues: Ser54, 59, 191
02 POUs POUs domain Nil Nil
03 POUh domain Nil 2 Residues: Ser301, 323
04 Linker region of POUs & POUh 1 Residue: Ser271 2 Residues: Ser274, 284
05 C-terminal region 6 Residues: Ser371, 389, 435, 441, 448, 452 1 Residues: Ser394
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In contrast to the ubiquitous expression of Oct-1, Oct-2
expression is restricted to B cells and neuronal cells (40).
In B cells and neuronal cells, the alternative splicing of
Oct-2 generates several proteins (41,42). On the basis of
transfection experiments, a critical role for immunoglobulin
promoter transactivation was shown for Oct-2 (41).
Recent studies (43) demonstrated that in addition to Oct-2,
a B-cell-specific cofactor, namely Bob-1, is required. Thus,
Figure 4. The phylogenetic tree generated by CLUSTALW with all sequences for mammalian, catfish and Drosophila Oct-2.
Figure 5. Sequence logos for different aligned regions of Oct-2. The conserved S/T residues with modification potential and with experimental evidence for
modification in the region they are located are marked by a blue asterisk on the top of these residues. Whereas other conserved Ser residues are marked by red asterisk,
which display either high or low potential as Yin Yang sites but lacking experimental evidence for modification in the region where they are located.
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B-cell specificity of immunoglobulin promoter activity is
mediated by the expression of Bob-1 (OCA-B or OBF-1)
which associates with the POU domain of the octamer
proteins Oct-1 and Oct-2 and alters their recognition
specificity (44).
The mechanisms involved in the activation of Oct-2 and
its recognition of protein and DNA binding sites are not yet
fully understood. The involvement of phosphorylation in the
POU domain for DNA binding (11) and that of the C-terminal
region for its activation (7,45) have been proposed. Phos-
phorylation of Oct-2 in vivo has been observed and its involve-
ment in transcription activation documented (7,11,12).
Pevzner et al. (11) analyzed the tryptic and chymotryptic
phosphorylated Oct-2 peptides and showed that the POU
domain-containing peptides were more phosphorylated than
any other domain. These authors further defined the possible
sites that may undergo phosphorylation. These represent a
total of 12 residues, including Ser 25, 27, 191 and Thr 30
and, in the N-terminal region, Ser 197, 208, 271, 274, 275,
278, 314 and 323 residues in the POUs and POUh domains. All
these residues are conserved in mammals (Figure 3 and
Table 3), but as far as the modification potential is concerned,
only Ser 25, 191, 271, 274, 278 and 323 are positive sites for
phosphorylation. Similarly, Ser271 is also a positive site for
O-GlcNAc modification and a potential Yin Yang site
(Figure 2). In addition, Ser191, 274, and 323 and Thr301
show strong potential for phosphorylation and were predicted
to be negative sites for O-GlcNAc, although very close to the
threshold. Thus, Ser191 in the N-terminal region close to the
POUs domain, Ser274 in the linker region of the POUs and
POUh sub-domains, and Ser323 and Thr301 in the POUh are
false negative Yin Yang sites (Table 3). It is important to note
that the Ser191 is conserved in all mammals and catfish, but
partly in Drosophila, while Thr301 is conserved in all mam-
mals, vertebrates and Drosophila (Table 3). Similarly, Ser274
and Ser323 are conserved in vertebrates and Drosophila
(Figure 3 and Table 3).
Phosphorylation of these residues may result in transient
conformational changes by disturbing the non-covalent inter-
actions and leading to down-regulation of expression of the
BLR1 gene expression in the mouse, as suggested by Pevzner
et al. (11). However, similar results were not found for human
lymphoid cells, which might be due to the blocking of phos-
phorylation sites by O-GlcNAc. From the modification poten-
tial and conserved behavior of these residues (Figure 5), we
propose that the Ser191, Ser274 and Ser323 are necessarily
involved in the differential binding behavior of Oct-2 to the
octamer DNA motif. Alternance of phosphorylation and
GlcNAc modification at such critical serines may indeed con-
trol the function of Oct-2 by influencing interactions of Oct-2
with the DNA octamer motifs.
Recently, Corcoran et al. (7) have suggested the possibility
of regulatory phosphorylation in the C-terminal region
of Oct-2, stressing the functional importance of this C-
terminal region. The signal for the C-terminal domain activa-
tion of Oct-2 was proposed to occur through phosphorylation.
The potential phosphorylatable residues in that region were
serines at positions 365, 389, 392, 393, 394, 396, 403 and 404,
and threonines at 397, 400 and 401. These residues are nearly
all conserved in mammals, but among these residues, Ser389
had potential for phosphorylation as well as O-GlcNAc
modification and was also a predicted Yin Yang site.
Ser394, 401 and 403, and Thr408, showed potential for phos-
phorylation but were negative for GlcNAc modification.
Ser394, however, is a false negative potential site for GlcNAc
modification, while it has a much higher potential than the
required threshold for phosphorylation. Thus, in the C-
terminal domain, Ser389 and Ser394 may be the potential
Yin Yang sites for regulating the activation of Oct-2 binding
through the interplay of the two PTMs (Figure 5).
There are other predicted Yin Yang sites in the Oct-2
N-terminal region, POU domains, linker region and
C-terminal region. However, for these sites, no experimental
evidence has been obtained until now but even so, the potential
of such other residues for modification by phosphate and
GlcNAc cannot be ignored. These sites include Ser49, 52,
68 in the N-terminal region, Ser249 in the POUs domain,
Ser271 in the linker region of the two POU subdomains
and Ser371, 435, 441, 448 and 452 in the C-terminal region
(Figure 5). Furthermore, there are other ’false negative’ sites
that could be considered true Yin Yang sites, as for instance
Ser54, 59 and Thr150, 172 in the N-terminal region, Ser284 in
the linker region of the two POU subdomains, Thr301 in the
POUh sub-domain and Ser394 in the C-terminal region
(Figure 5). Among these residues the most important Yin
Yang site in C-terminal region seems to be Ser371, which
is predicted by the YinOYang 1.2 method (Figure 2), as
well as one of the conserved residues in all mammalian
Oct-2 and a conserved or semi-conserved substitution in
other species (Figure 5). The possibility of Ser371 as potential
Yin Yang site is strengthened by the fact that it has Pro at
2 and +3 position, a configuration that favors O-linked
glycosylation (46).
Significance of different amino acid residues around glyco-
sylation sites has been described (46). Proline, Ser, Thr and
Ala are highly preferred around glycosylated Ser/Thr (46).
Calculations based on deviation parameter analysis also
showed that among these residues Pro at 3, 1, +1, +2,
+3 and +5 positions is highly preferred around glycosylated
Ser/Thr (46). Valine at 1 position has been described to be
preferred around glycosylated Ser/Thr. Previously, it was
described (47,48) that amino acids with small side chain
are important in the vicinity of glycosylation site of Ser/
Thr, for example Gly at 2 and +2 position was described
to be associated with higher degree of glycosylation. Simi-
larly, conserved Pro at +1 position was described to favor
phosphorylation (49). Figure 5 shows that most of the pro-
posed Yin Yang sites (Table 3) on Ser/Thr have Pro, Val, Ser,
Thr or Gly in their vicinity. Conserved Pro is closely located to
nearly all the proposed Ser/Thr interplay sites, and in some
cases conserved Val, Gly, Ser or Thr are also present (Figure 5)
in the vicinity of these Yin Yang sites.
On the basis of our prediction results and available experi-
mental data, we propose that interplay of phosphorylation and
GlcNAc modification at Ser and Thr residues in the C-terminal
region of various domains of the Oct-2 transcription factor is
apparent. This suggests that interplay sites can play an impor-
tant role in regulating Oct-2 functions. Our results indeed show
that in the C-terminal domain, Ser residues 371, 389 and 394
are potential Yin Yang sites and may contribute significantly
in regulating the activation of Oct-2 binding. Furthermore,
alternative phosphorylation and O-GlcNAc modification at
182 Nucleic Acids Research, 2006, Vol. 34, No. 1
Ser191, in the N-terminal region, at Ser271 and 274 in the
linker region of the two POU sub-domains and at Thr301 and
Ser323 in the POUh sub-domain are likely to promote differ-
ential binding behavior of Oct-2 to the DNA octamer.
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